Australia Eliminates Trachoma as a Public Health Problem: A Landmark Win for Indigenous Health

In a major victory for public health and health equity, the World Health Organization (WHO) has officially validated Australia for eliminating trachoma as a public health problem. This achievement marks a critical milestone in the health of Indigenous peoples and represents a significant step forward in the global fight against neglected tropical diseases (NTDs).

Trachoma, once a persistent threat in remote areas, is the world’s leading infectious cause of blindness. For Australia, this validation is more than just a statistic; it’s the result of decades of targeted action, community leadership, and a commitment to reaching the most vulnerable populations.

What is Trachoma and Why is it Dangerous?

Trachoma is caused by the bacterium Chlamydia trachomatis. It doesn’t just appear; it spreads through close contact with infected individuals, contaminated surfaces, and flies that carry discharge from the eyes and nose.

While a single infection might seem minor, repeated infections lead to severe complications. Over time, the infection can cause the eyelids to scar, which eventually turns the eyelashes inward (a condition known as trichiasis). If left untreated, these eyelashes scrape against the eyeball, leading to permanent blindness.

The Road to Success: The SAFE Strategy

Australia’s journey to elimination intensified in 2006 with the establishment of the National Trachoma Management Programme. The program didn’t reinvent the wheel; instead, it implemented the WHO-recommended SAFE strategy, a comprehensive four-pronged approach:

• Surgery to treat trichiasis (the inward-turning eyelashes).
• Antibiotics to treat the active infection.
• Facial cleanliness to prevent the spread of the bacteria.
• Environmental improvement, specifically focusing on water, sanitation, and hygiene (WASH) and housing.

Rather than relying on mass drug administration, Australia adapted this strategy to its specific context, using community-level data to target treatments and integrating these efforts with broader environmental health programs.

“This success reflects sustained commitment, strong partnerships, and a focus on reaching populations most affected by health inequities. It brings us closer to a world free from the suffering caused by trachoma.”
— Dr. Tedros Adhanom Ghebreyesus, WHO Director-General

Community-Led Health: The Heart of the Achievement

The elimination of trachoma was not a top-down mandate but a collaborative effort. The success relied heavily on partnerships between federal and state governments, local communities, and Aboriginal community-controlled health services.

Aboriginal and Torres Strait Islander leadership was central to this process. Local health workers in remote First Nations communities delivered culturally safe care and community-led solutions, ensuring that interventions were effective and respected.

Mark Butler, Australia’s Minister for Health and Ageing, noted that this milestone is a “win for the eye health of communities across Australia,” attributing the success to sustained investment and Indigenous leadership. Similarly, Malarndirri McCarthy, Minister for Indigenous Australians, emphasized that the work of Aboriginal Community Controlled Health Organisations was critical to this outcome.

The Bigger Picture: Neglected Tropical Diseases (NTDs)

Trachoma is one of 21 diseases categorized by the WHO as Neglected Tropical Diseases (NTDs). These conditions primarily affect underserved populations with limited access to clean water and basic healthcare, impacting more than 1 billion people worldwide.

Australia’s achievement places it among a growing number of countries contributing to the WHO road map for NTDs 2021–2030. By eliminating trachoma, Australia becomes the 63rd country globally and the 16th in the Western Pacific Region to eliminate at least one NTD.

Despite this win, the work isn’t over. Australia still manages other endemic NTDs, including scabies, leprosy, and Buruli ulcer. The lessons learned from the trachoma program—specifically the importance of cross-sectoral collaboration and community leadership—will now inform how the country approaches other preventable health conditions in regional and remote areas.

Key Takeaways: Australia’s Trachoma Elimination

• The Cause: Trachoma is caused by Chlamydia trachomatis and can lead to permanent blindness.
• The Method: Australia used the WHO’s SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement).
• The Driver: Success was driven by Aboriginal Community Controlled Health Organisations and local First Nations health workers.
• The Global Rank: Australia is the 63rd country globally to eliminate at least one NTD.
• The Goal: This progress supports the WHO’s global target to eliminate trachoma as a public health problem by 2030.

Technical Breakdown: How WHO Defines “Elimination”

When the WHO validates the “elimination of trachoma as a public health problem,” it isn’t saying every single case is gone. Instead, it means the disease no longer poses a significant threat to the population. The specific criteria include:

1. A prevalence of trachomatous trichiasis (TT) (unknown to the health system) of less than 0.2% in people aged 15 years and older.
2. A prevalence of trachomatous inflammation—follicular (TF) in children aged 1–9 years of less than 5% in each formerly endemic district.
3. The existence of a functioning system to identify and manage new cases of TT.

Looking Ahead

While the validation is a cause for celebration, health officials warn against complacency. Dr. Saia Ma’u Piukala, WHO Regional Director for the Western Pacific, has urged all involved to remain vigilant to ensure the country maintains its elimination status. Sustained surveillance, integrated into national health systems, will be essential to prevent the disease from returning.